Late last year, Lilly was the first pharmaceutical stock to reach a $1 trillion valuation.
Diabetes
Study shows evidence of growing early gestational diabetes among pregnant women
The focus is on identifying the right timing, tests, and treatments for GDM to improve outcomes…
Novo Nordisk’s oral GLP-1 drug didn’t work on Alzheimer’s as hoped, and the stock tumbles
Novo Nordisk’s stock tumbles after its oral GLP-1 drug failed to show much benefit over a…
Health Matters newsletter Stress and the shifting map of health
(In the weekly Health Matters newsletter, Athira Elssa Johnson writes about getting to good health, and staying there. You…
The Role of GLP-1RAs in India, ETHealthworld
It’s been 20 years since the FDA approved the first glucagon-like peptide-1 receptor agonist (GLP-1RA), fundamentally…
There’s still hope GLP-1 drugs could slow the second-biggest type of dementia
Published: Nov. 24, 2025 at 4:57 p.m. ET There’s rarely good news about Alzheimer’s disease, but a…